NVS has been in the news 375% more than usual
Aug 12, 2025, 2:31 PM
6.06%
What does NVS do
It seems the content is not visible or provided. Please share the content you'd like summarized, and I'd be happy to help!
NVS has been in the news recently: Novartis AG reported promising topline results from two Phase III trials of ianalumab, demonstrating a significant reduction in disease activity for patients with active Sjögren's disease. Additionally, the company shared results from the VAYHIT2 trial, highlighting the efficacy of ianalumab combined with eltrombopag in patients with corticosteroid-treated primary immune thrombocytopenia.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.